Immune monitoring of tumor course

In the course of diseases such as cancer, autoimmune diseases and infectious diseases, the diversity of TCR repertoire is significantly lower than that of normal subjects and normal tissues of patients. In the process of treatment, TCR repertoire diversity will change accordingly.


By sequencing TCR repertoire, the entire course of disease progression can be monitored to reflect therapeutic effects in real time.


Beijing City, Changping District small town life Zhongguancun Life Science Park Road No. 8 School District No. 6 Building 4 layer


No.101 5-10-2 Cuibo Road, Chunhui Street,Dadukou District, Chongqing

Contact us

© 2017 Chongqing TCRCure Biological Technology Co Ltd. All Rights Reserved.  渝ICP备17005995号  Powered by: www.300.cnManager